HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

On the pathogenesis of acquired hypo-beta-lipoproteinemia. A case associated with sideroblastic anemia.

Abstract
A 71-year-old previously hypercholesterolemic woman developed gradually severe hypocholesterolemia of 1.55 mmol/l. Simultaneously she developed progressive sideroblastic anemia, altered erythrocyte morphology and defective platelet function. Hypo-beta-lipoproteinemia was demonstrated with abnormal lipid composition of both very low density (VLDL), low density (LDL) and high density lipoprotein (HDL) fractions. Other plasma lipids, as well as erythrocyte lipids, were normal. The fractional catabolic rate of homologous 125I-LDL was increased to 4-5-fold, while its rate of synthesis was normal. The patient's serum contained autoantibodies directed against LDL. It is concluded that her hypo-beta-lipoproteinemia was due to autoantibodies towards LDL causing an increased catabolism without any concomitant effect on the rate of LDL synthesis. It is suggested that acquired hypo-beta-lipoproteinemia can be subdivided into two types, one in which the primary defect is an increased catabolism due to immunoelimination, and another in which the primary defect is a decreased rate of LDL synthesis.
AuthorsK S Bjerve, S A Evensen, S Stray-Pedersen, S Skrede
JournalActa medica Scandinavica (Acta Med Scand) Vol. 211 Issue 4 Pg. 313-8 ( 1982) ISSN: 0001-6101 [Print] Sweden
PMID7102370 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Autoantibodies
  • Lipoproteins, HDL
  • Lipoproteins, LDL
  • Lipoproteins, VLDL
Topics
  • Aged
  • Anemia, Sideroblastic (etiology)
  • Autoantibodies (analysis)
  • Female
  • Humans
  • Hypercholesterolemia (complications)
  • Hypobetalipoproteinemias (etiology, immunology, metabolism)
  • Hypolipoproteinemias (etiology)
  • Lipoproteins, HDL (metabolism)
  • Lipoproteins, LDL (immunology, metabolism)
  • Lipoproteins, VLDL (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: